La Jolla Pharmaceutical Company 13D and 13G filings for TETRAPHASE PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-29 5:18 pm Purchase |
2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
7,263,236 100.000% |
6,178,236 (+569.42%) |
Filing |
| 2020-06-30 5:37 pm Unchanged |
2020-06-29 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
0 (Unchanged) |
Filing |
| 2020-06-25 9:58 pm Unchanged |
2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
0 (Unchanged) |
Filing |
| 2020-06-22 5:17 pm Purchase |
2020-06-15 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
1,085,000 (New Position) |
Filing |